These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
93 related items for PubMed ID: 24990095
1. Zebrafish as a new model for phenotype-based screening of positive inotropic agents. Tang C, Xie D, Feng B. Chem Biol Drug Des; 2015 Mar; 85(3):253-8. PubMed ID: 24990095 [Abstract] [Full Text] [Related]
2. Synthesis and positive inotropic activity evaluation of liguzinediol metabolites. Zhu HH, Chen YQ, Cheng D, Li W, Wang TL, Wen HM, Chen L, Liu J. Bioorg Med Chem Lett; 2016 Feb 01; 26(3):882-884. PubMed ID: 26725025 [Abstract] [Full Text] [Related]
15. [Positive inotropic substances (digitoxin, digoxin). Principles and rules of use]. Haïat R. Rev Prat; 1997 Oct 01; 47(15):1723-7. PubMed ID: 9406521 [No Abstract] [Full Text] [Related]
16. Inotropic activity of digitoxigenin glucoside and related glycosides. Altman PM, Einstein R, Goodman AH, Thomas RE. Arzneimittelforschung; 1988 Aug 01; 38(8):1115-9. PubMed ID: 3196405 [Abstract] [Full Text] [Related]
17. [New inotropic agents in the treatment of congestive heart failure]. Freitas M. Rev Port Cardiol; 1993 Nov 01; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458 [Abstract] [Full Text] [Related]
18. Digoxin in the management of cardiovascular disorders. Gheorghiade M, Adams KF, Colucci WS. Circulation; 2004 Jun 22; 109(24):2959-64. PubMed ID: 15210613 [No Abstract] [Full Text] [Related]
19. 200+ years of a misunderstood drug for treating chronic heart failure: digoxin, why and how should we continue using it? Hothi SS, Chinnappa S, Tan LB. Int J Cardiol; 2013 Sep 30; 168(2):645-7. PubMed ID: 22608274 [No Abstract] [Full Text] [Related]
20. Controversy in heart failure management: Digoxin use in the elderly. Chun J, Chodosh J. J Am Med Dir Assoc; 2006 Nov 30; 7(9):581-6. PubMed ID: 17095423 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]